Skip to main content

Labeled for this condition

Medicines for insomnia

14 medicines have an FDA label indicated for insomnia; 10 are listed from generic labelers and 1 has a presentation in shortage now (FDA files, October 8, 2026).

Which medicines are labeled for insomnia?

Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.

Recalls: FDA enforcement reports, 2012 on
MedicineBrand namesGeneric labelers (all forms)Pharmacy costBoxed warningShortageRecalls since 2012
DoxepinSilenor, Prudoxin, Zonalon49 labelers$0.0779 per capsule 10 mg capsuleYesNo current entry2
ZolpidemAmbien, Edluar39 labelers$0.0344 per tablet 5 mg tabletYesNo current entry6
EszopicloneLunesta27 labelers$0.0993 per tablet 1 mg tabletYesNo current entry2
TemazepamRestoril20 labelers$0.0767 per capsule 15 mg capsuleYesNo current entry1
RamelteonRozerem27 labelers$0.660 per tablet 8 mg tabletNoA presentation being discontinued0
Zaleplonnone listed9 labelers$0.141 per capsule 10 mg capsuleYesNo current entry0
Triazolamnone listed7 labelers$0.308 per tablet 0.25 mg tabletYesNo current entry0
Estazolamnone listed3 labelers$0.839 per tablet 2 mg tabletYesNo current entry0
SuvorexantBelsomranone listed$15.21 per tablet 10 mg tabletNoNo current entry2
DaridorexantQuviviqnone listed$16.70 per tablet 25 mg tabletNoNo current entry0
Flurazepamnone listed1 labelern/aYesIn shortage0
LemborexantDayvigonone listed$11.57 per tablet 10 mg tabletNoNo current entry0
Pentobarbitalnone listed2 labelersn/aNoNo current entry0
Quazepamnone listednone listedn/aYesNo current entry0

Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?